Biotechnology

Found 39,728 articles

• Alpha Tau Medical to Participate in June 2023 Investor Conferences

  5/24/2023

  Alpha Tau Medical Ltd., the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced that management will participate in the following investor conferences.

• Adaptive Biotechnologies to Participate in Upcoming June 2023 Investor Conferences

  5/24/2023

  Adaptive Biotechnologies Corporation, a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, announced it will be participating in the following investor conferences.

• Spruce Biosciences to Participate in the 2023 Jefferies Healthcare Conference

  5/24/2023

  Spruce Biosciences, Inc. announced that Javier Szwarcberg, M.D., M.P.H., Chief Executive Officer, will present at the Jefferies Healthcare Conference on June 9, 2023, at 9:30 a.m. ET.

• Iveric Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 24, 2023

  5/24/2023

  IVERIC bio, Inc. reported that on May 19, 2023, the Company granted equity-based awards pursuant to the Company’s 2019 Inducement Stock Incentive Plan to 63 newly-hired, non-executive employees.

• Mirati Therapeutics Provides Update on the Phase 3 SAPPHIRE Study Evaluating Sitravatinib in Combination with OPDIVO®

  5/24/2023

  Mirati Therapeutics, Inc.®, a commercial-stage oncology company, announced that the SAPPHIRE study did not meet its primary endpoint of overall survival at the final analysis.

• SomaLogic to Participate in the 2023 Jefferies Healthcare Conference

  5/24/2023

  SomaLogic, Inc., a leader in proteomics technology, announced that the company will be participating in the upcoming Jefferies Healthcare Conference.

• Carina Biotech to Participate in Three Upcoming June 2023 Conferences

  5/24/2023

  Carina Biotech, a cell therapy immuno-oncology company, announced that the management team will participate in the three upcoming conferences as follows:

• Aura Biosciences to Participate in Upcoming Investor Conferences - May 24, 2023

  5/24/2023

  Aura Biosciences Inc. announced that Elisabet de los Pinos, PhD, Chief Executive Officer, will participate in the following upcoming investor conferences: TD Cowen 4th Annual Oncology Innovation Summit on Tuesday, May 30, 2023.

• Nuvalent to Participate in the TD Cowen 4th Annual Oncology Innovation Summit

  5/24/2023

  Nuvalent, Inc. announced that James Porter, Ph.D., Chief Executive Officer, and Alexandra Balcom, Chief Financial Officer, will participate in a fireside chat during the TD Cowen 4th Annual Oncology Innovation Summit on Wednesday, May 31, 2023, at 10:30 a.m. ET.

• 10x Genomics Launches Visium CytAssist Gene and Protein Expression Assay

  5/24/2023

  10x Genomics, Inc., a leader in single cell and spatial biology, announced the commercial availability of a new Visium CytAssist Gene and Protein Expression product to expand the breadth of the Visium CytAssist spatial analysis capabilities.

• Aligos Therapeutics to Present at the Jefferies 2023 Healthcare Conference

  5/24/2023

  Aligos Therapeutics, Inc. announced that Lawrence M. Blatt, Ph.D., MBA, Chairman and CEO of Aligos, will present at the Jefferies Healthcare Conference on Thursday, June 8, 2023 at 8:00 a.m. ET.

• GeneDx to Participate in Upcoming Investor Conferences in June 2023

  5/24/2023

  GeneDx, a leader in delivering improved health outcomes through genomic and clinical insights, announced that management will participate at the following investor conferences in June.

• Touchlight Completes Expansion, Creating One of the World’s Largest DNA Manufacturing Facilities in London, UK

  5/24/2023

  Facility will have capacity that exceeds global plasmid DNA demand and can enable commercialisation of genetic medicines.

• Relay Therapeutics to Participate in Two Upcoming Investor Conferences - May 24, 2023

  5/24/2023

  Relay Therapeutics, Inc. announced that management will participate in two upcoming fireside chats.

• Kineta Set to Join Russell Microcap® Index

  5/24/2023

  Kineta, Inc. announced that the company is set to join the Russell Microcap® Index at the conclusion of the 2023 Russell indexes annual reconstitution, effective after the US market opens on June 26, 2023, according to a preliminary list of additions posted on May 19, 2023.

• CytoDyn Announces President Takes Medical Leave of Absence

  5/24/2023

  CytoDyn Inc., a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced that Dr. Cyrus Arman, the Company’s President, has taken a medical leave of absence.

• Gracell Biotechnologies to Participate in 2023 Jefferies Healthcare Conference

  5/24/2023

  Gracell Biotechnologies Inc. announced that the management team will participate in the Jefferies Healthcare Conference on June 8, 2023, in New York, NY.

• Breakthrough Results: Defence's Arm Vaccine Cured 100% of Animals with Pre-Established Lymphoma

  5/24/2023

  Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the "Company"), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies

• Allogene Therapeutics Announces Participation in Three Upcoming Investor Conferences - May 24, 2023

  5/24/2023

  Allogene Therapeutics, Inc. today announced that it will participate in three upcoming investor conferences.

• Gate Neurosciences to Highlight New Biomarker Data & Host R&D Day at 2023 ASCP Annual Meeting

  5/24/2023

  Highlighting new biomarker data and research supporting precision development of the “‘stinel” class at the 2023 ASCP Annual Meeting.